Cargando…

Hypophosphatemia after high-dose intravenous iron treatment in patients with inflammatory bowel disease: Mechanisms and possible clinical impact

BACKGROUND: High-dose intravenous iron is an effective treatment option for iron deficiency (ID) or ID anaemia (IDA) in inflammatory bowel disease (IBD). However, treatment with ferric carboxymaltose (FCM) has been associated with the development of hypophosphatemia. AIM: To investigate mechanisms b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Detlie, Trond Espen, Lindstrøm, Jonas Christoffer, Jahnsen, Marte Eide, Finnes, Elisabeth, Zoller, Heinz, Moum, Bjørn, Jahnsen, Jørgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108035/ https://www.ncbi.nlm.nih.gov/pubmed/34007138 http://dx.doi.org/10.3748/wjg.v27.i17.2039

Ejemplares similares

Fatigue is not associated with vitamin D deficiency in inflammatory bowel disease patients
por: Frigstad, Svein Oskar, et al.
Publicado: (2018)

Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk
por: Schaefer, Benedikt, et al.
Publicado: (2016)

Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character Cohort
por: Vatn, Simen Svendsen, et al.
Publicado: (2022)

Intravenous Iron Induced Severe Hypophosphatemia
por: Guo, Rong R, et al.
Publicado: (2021)

Self-esteem in patients with inflammatory bowel disease
por: Opheim, Randi, et al.
Publicado: (2020)

Intravenous Iron Administration and Hypophosphatemia in Clinical Practice
por: Hardy, S., et al.
Publicado: (2015)

Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome
por: Glaspy, John A., et al.
Publicado: (2021)

Recurrent severe hypophosphatemia following intravenous iron administration
por: Nataatmadja, Melissa Stephanie, et al.
Publicado: (2020)

Validity, Reliability, and Responsiveness of the Brief Pain Inventory in Inflammatory Bowel Disease
por: Jelsness-Jørgensen, Lars-Petter, et al.
Publicado: (2016)

The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel Disease
por: Horrigan, Jamie M, et al.
Publicado: (2023)

Combination of Biological Agents in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Case Series and Review of the Literature
por: Olbjørn, Christine, et al.
Publicado: (2020)

The prevalence and transcriptional activity of the mucosal microbiota of ulcerative colitis patients
por: Moen, Aina E. Fossum, et al.
Publicado: (2018)

Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review
por: Glaspy, John A, et al.
Publicado: (2020)

Hypophosphatemia in children treated with ferric carboxymaltose
por: Posod, Anna, et al.
Publicado: (2020)

Pain Severity and Vitamin D Deficiency in IBD Patients
por: Frigstad, Svein Oskar, et al.
Publicado: (2019)

Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose
por: Schaefer, Benedikt, et al.
Publicado: (2021)

MON-338 Severe Hypophosphatemia Induced by Intravenous Ferric Carboxymaltose Therapy for Iron Deficiency Anemia
por: Tam, Matthew, et al.
Publicado: (2020)

Alcohol and drug use disorders in adult attention-deficit/hyperactivity disorder: Prevalence and associations with attention-deficit/hyperactivity disorder symptom severity and emotional dysregulation
por: Anker, Espen, et al.
Publicado: (2020)

Single cell transcriptomic analysis of the immune cell compartment in the human small intestine and in Celiac disease
por: Atlasy, Nader, et al.
Publicado: (2022)

Sharp rises in FGF23 and hypophosphatemia after intravenous iron administration do not cause myocardial damage
por: Brandenburg, Vincent, et al.
Publicado: (2020)

Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose
por: Fang, Wendy, et al.
Publicado: (2019)

Risk of Cancer in Patients With Crohn’s Disease 30 Years After Diagnosis (the IBSEN Study)
por: Follin-Arbelet, Benoit, et al.
Publicado: (2023)

Characterization of Regulatory T-Cell Markers in CD4+ T Cells of the Upper Airway Mucosa
por: Ballke, Christina, et al.
Publicado: (2016)

Health-related quality of life in patients with newly diagnosed inflammatory bowel disease: an observational prospective cohort study (IBSEN III)
por: Olsen, Bjorn Christian, et al.
Publicado: (2023)

Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study
por: Klepp, Pasquale, et al.
Publicado: (2020)

Appropriateness of the study of iron deficiency anemia prior to referral for small bowel evaluation at a tertiary center
por: Rodrigues, Jaime Pereira, et al.
Publicado: (2017)

Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study
por: Johansen, Ingunn, et al.
Publicado: (2023)

Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease – associations with disease phenotype, treatment, and outcome
por: Olbjørn, Christine, et al.
Publicado: (2019)

Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2
por: Nowak, Jan K, et al.
Publicado: (2022)

Real-life chromoendoscopy for dysplasia surveillance in ulcerative colitis
por: Klepp, Pasquale, et al.
Publicado: (2018)

Outcome of Ulcerative Colitis 20 Years after Diagnosis in a Prospective Population-based Inception Cohort from South-Eastern Norway, the IBSEN Study
por: Monstad, Iril Lovise, et al.
Publicado: (2020)

A rare case of parental iron-induced persistent hypophosphatemia
por: Sullivan, Abigayle, et al.
Publicado: (2020)

Photodynamic Effects with 5-Aminolevulinic Acid on Cytokines and Exosomes in Human Peripheral Blood Mononuclear Cells from Patients with Crohn’s Disease
por: Espeland, Kristian, et al.
Publicado: (2023)

Incidence and Prevalence of Inflammatory Bowel Disease in Norway and the Impact of Different Case Definitions: A Nationwide Registry Study
por: Lirhus, Sandre Svatun, et al.
Publicado: (2021)

Candida albicans Oropharyngeal Infection Is an Exception to Iron-Based Nutritional Immunity
por: Solis, Norma V., et al.
Publicado: (2023)

The Use of Complementary and Alternative Medicine among Patients with Inflammatory Bowel Disease Is Associated with Reduced Health-Related Quality of Life
por: Opheim, Randi, et al.
Publicado: (2016)

A Single Bacterium Capable of Oxidation and Reduction of Iron at Circumneutral pH
por: Kato, Shingo, et al.
Publicado: (2021)

PATIENTS WITH INFLAMMATORY BOWEL DISEASE PERSPECTIVE ON COVID-19 AND HEALTH CARE SERVICE DURING THE PANDEMIC
por: Opheim, Randi, et al.
Publicado: (2021)

Incidence of Hypophosphatemia After Intravenous Administration of Iron: A Matching-Adjusted Indirect Comparison of Data from Japanese Randomized Controlled Trials
por: Fukumoto, Seiji, et al.
Publicado: (2023)

Effects of electroacupuncture on bladder and bowel function in patients with transverse myelitis: a prospective observational study
por: Wu, Jiani, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qhpstftqmtkta2lqsdid4102n8